Skip to content

Noom Monitor for Binge Eating

Noom Monitor for Binge Eating

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02555553
Enrollment
225
Registered
2015-09-21
Start date
2016-04-30
Completion date
2018-05-01
Last updated
2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge Eating Disorder

Keywords

Cognitive behavioral therapy guided self-help, Mobile Mental Health, Binge Eating, Cognitive Behavioral Therapy, Eating Disorder Treatment, Self-monitoring, Eating Disorders, Ecological Momentary Intervention

Brief summary

The purpose of the proposed Phase II STTR study is to test the primary efficacy of a novel mobile app, 'Noom Monitor,' in a large population of binge eaters in the Kaiser Permanente health care system relative to a well-established treatment as usual (TAU) control condition. Noom Monitor facilitates the delivery of CBT-GSH by utilizing a patient interface that increases adherence and provides between-session reminders of CBT-GSH principles. In addition, the Noom Monitor includes a therapist interface with weekly feedback to the provider about patient progress. This application has several primary objectives, including: (1) testing the real-world effectiveness of the Noom Monitor in a clinical setting, and (2) establishing a database of training materials for Noom Monitor. The knowledge gained from the current study will contribute to our understanding of the role of new emerging mobile technologies in augmenting existing treatments.

Detailed description

Binge eating is a core maladaptive behavior characteristic of several forms of eating pathology, including bulimia nervosa (BN) and binge eating disorder (BED). These chronic conditions affect approximately 5% of the population, and cause significant psychosocial and physical impairment. However, a number of barriers prevent the implementation of effective treatments, including poor treatment adherence, a paucity of specialized therapists, and high rates of drop out. The guided self-help version of cognitive-behavior therapy (CBT-GSH) is a brief 8-session highly scalable treatment to reduce binge eating. Moreover, CBT-GSH is a cost-effective empirically supported treatment that has been demonstrated to reduce total health care costs. Although CBT-GSH for BN and BED is effective, few individuals receive these treatments and the majority of other available treatments do not meet adequate standards for care for eating disorders. There are a number of reasons for why this is the case, but an important concern about CBT-GSH is participant burden. The primary CBT-GSH intervention is self-monitoring, a uniquely effective technique for reducing binge eating episodes; however, traditional self-monitoring is time-intensive and cumbersome because of its paper-and-pencil format. In addition, other behavioral strategies utilized in CBT-GSH (e.g., the development of regular eating) require a high degree of participant engagement outside of session. Novel technologies, such as those available with smartphones, offer potentially important means for reducing participant burden in the delivery of CBT-GSH. The purpose of the proposed is to test the primary efficacy of a novel mobile app, 'Noom Monitor' in a large population of binge eaters relative to a well-established treatment as usual (TAU) control condition. The investigative team developed these products via phase I study (R41-MH096435) to facilitate delivery of a cognitive-behavior therapy version of Guided Self-Help. The efficacy and product development aims of this proposal will be used to support the commercial launch of Noom Monitor, a smartphone platform.

Interventions

BEHAVIORALCBT-GSH with Noom Monitor

This intervention is cognitive behavioral treatment with a smartphone application

Sponsors

Noom Inc.
CollaboratorINDUSTRY
Kaiser Permanente
CollaboratorOTHER
Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Meets for DSM-5 BN or BED criteria * Between the ages of 18 and 55 * Males and females * BMI greater than 18.5 and less than 40 * Medical clearance in the case of reported purging or extreme exercise * Free of psychiatric medication for at least 2 weeks prior to study or on a stable dose of medication for 4 weeks * 1 year continuous enrollment in Kaiser Permanente Northwest health plan

Exclusion criteria

* Has undergone bariatric surgery * Demonstrates need for higher level of care (e.g., very low weight (\<18.5)) * Current comorbid substance dependence, bipolar or psychotic illness * Current suicidal ideation * Previously received Enhance Cognitive behavioral therapy or Cognitive behavioral therapy-guided self help * Previously read Overcoming Binge Eating by Christopher Fairburn * Purging and/or laxative use more than 2x a day on average over the last month.

Design outcomes

Primary

MeasureTime frameDescription
Objective Binge DaysAt 0 weekObjective Binge Days - Objective binge days item of Eating Disorder Examination Scale version 16 (EDE-Q V6) - Frequency of days with objective binge episodes
Sum of Compensatory EpisodesAt 0 weekSum of days where vomiting, laxative, or compulsive exercise occurs - sum of 3 items on EDE-Q v6

Secondary

MeasureTime frameDescription
Quality of Life ScaleAt 0 weekFull scale from 16-112, with higher score indicating better health outcomes
Eating Concern SubscaleAt 0 weekEating concern subscale of the EDE-QV6 from 0-6 with higher score indicating worse health outcomes
Dietary Restraint SubscaleAt 0 weekDietary Restraint Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Clinical Impairment AssessmentAt 0 weekFull scale from 0-48, with higher score indicating more impairment
Weight Concern SubscaleAt 0 WeekWeight Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Global Eating Disorder SubscaleAt 0 weekGlobal Eating Disorder Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Shape Concern SubscaleAt 0 weekShape Concern Subscale of the EDE-Q v6 from 0-6, with higher score indicating worse health outcomes
Personal Health QuestionnaireAt 0 weeksFull scale from 0-24, with higher score indicating more depression

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026